Article Text

PDF

Tumour necrosis factor microsatellite association with human papillomavirus cervical infection
  1. R T Simões1,
  2. J S R Bettini1,
  3. E G Soares1,
  4. G Duarte2,
  5. M A G Gonçalves3,
  6. A L Simões4
  1. 1Department of Pathology, School of Medicine of Ribeirão Preto, University of São Paulo, Av. Bandeirantes, 3900, 14049–900, Ribeirão Preto, SP–Brazil
  2. 2Department of Gynecology and Obstetrics, School of Medicine of Ribeirão Preto
  3. 3Division of Clinical Immunology, Department of Medicine, School of Medicine of Ribeirão Preto
  4. 4Department of Genetics, School of Medicine of Ribeirão Preto, University of São Paulo, Av. Bandeirantes, 3900, 14049–900, Ribeirão Preto, SP–Brazil; alsimoes{at}fmrp.usp.br

    Statistics from Altmetric.com

    Cervical cancer is the second most common cancer in the female population worldwide, and human papillomavirus (HPV) DNA has been isolated from more than 90% of these carcinomas. Immunoregulatory/antitumour mechanisms include cytokines that interfere directly with HPV harbouring cells. Among these cytokines, tumour necrosis factor α (TNFα) is released by HPV infected cells and inhibits the growth of transformed cell lines.1

    TNFα is a proinflammatory/antitumour cytokine that is indispensable to the inflammatory response. The TNF locus contains several polymorphic areas, including five microsatellite markers—a, b, c, d, and e—which contain 14, 7, 2, 7, and 3 alleles, respectively. These microsatellites are associated with different degrees of TNFα secretion, and are related to a greater susceptibility to developing autoimmune and infectious diseases. A recent study reported several associations between TNF microsatellites and cancer, among other diseases.2 However, up to now, the association of these markers with HPV and the progression to cervical intraepithelial neoplasia has only been studied by Ghaderi et al,3 who focused specifically on TNFa alleles. The objective of our study was to verify the frequencies of TNF microsatellite alleles (a–e) in 106 patients with HPV cervical infection and to compare these frequencies with the results from 101 healthy controls.

    In accordance with ethical norms, blood samples and cervical scrapings were collected from all patients at the time of their consultation. DNA was extracted from blood and scraped samples by the method of Higuchi.4 Primers and conditions for the polymerase chain reaction (PCR) have been described elsewhere.5,6 PCR products were electrophoresed on 12% denaturing polyacrylamide gels at 20 mA for TNF (a–e) and a 10% non–denaturing gel at 200 V for HPV; both gels were silver stained (fig 1). The allelic frequencies of the five TNFα microsatellite alleles were tested, for a total of 32 analyses (GENEPOP software; Population Genetics Software Package; M Raymond and F Rousset, http://wbiomed.curtin.edu.au/genepop/genepop_op1.html). No significant difference was found between the two populations (table 1). Among all the alleles, only TNFa*8 showed a significant association with HPV infection (χ2 = 4.79; relative risk, 10.73; 95% confidence interval, 1.28 to 89.9).

    Our present study is the first to analyse the association of five microsatellites (a–e) of the TNF gene with cervical HPV infection, irrespective of HPV type and lesion grade. According to our results, women carrying the TNFa*8 allele had a 10 times greater risk of being infected with HPV than did the control group. In contrast with data reported by Ghaderi et al,3 our analyses did not reveal an association between the TNFa*11 allele and HPV infection. Further studies are currently under way in our laboratory to determine whether the presence of specific microsatellites of the TNF gene are related to high risk HPV types or high grade cervical lesions.

    Table 1

    Allelic distribution of tumour necrosis factor α (TNFα) microsatellites in 106 patients (n=212) and 101 controls (n=202)

    Figure 1

    Polymerase chain reaction (PCR) analysis using electrophoresis on a 12% denaturing gel of (A) the tumour necrosis factor α a (TNFa) allele, (B) the TNFb allele, (C) the TNFc allele, (D), the TNFd allele, and (E) the TNFe allele. (F) PCR analysis using electrophoresis on a non–denaturing 10% polyacrylamide gel of human papillomavirus (HPV). Lane 1, patient number 1 (HPV positive); lane 2, patient number 2 (HPV positive); C+, positive control; C−, negative control; M, DNA molecular weight markers (50 bp).

    Acknowledgments

    We thank Dr EA Donadi for help with revising this manuscript. This work was supported by FAPESP (n.00/12371–3) and CAPES (n. DS 103/00).

    References

    View Abstract

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.